These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8739803)

  • 21. Naloxone modulates NK-cell activity of human peripheral blood lymphocytes like an opioid agonist.
    Martin-Kleiner I; Gabrilovac J
    Immunopharmacol Immunotoxicol; 1993; 15(2-3):179-97. PubMed ID: 7688780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Met-enkephalin modulates stress-induced alterations of the immune response in mice.
    Marotti T; Gabrilovac J; Rabatic S; Smejkal-Jagar L; Rocic B; Haberstock H
    Pharmacol Biochem Behav; 1996 May; 54(1):277-84. PubMed ID: 8728569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon induces natural killer cell blastogenesis in vivo.
    Biron CA; Sonnenfeld G; Welsh RM
    J Leukoc Biol; 1984 Jan; 35(1):31-7. PubMed ID: 6200554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF; Biron CA; Welsh RM
    J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production.
    Handa K; Suzuki R; Matsui H; Shimizu Y; Kumagai K
    J Immunol; 1983 Feb; 130(2):988-92. PubMed ID: 6294182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro augmentation of natural killer cell activity by manganese chloride.
    Smialowicz RJ; Rogers RR; Riddle MM; Rowe DG; Luebke RW
    J Toxicol Environ Health; 1986; 19(2):243-54. PubMed ID: 2428983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganoderma tsugae mycelium enhances splenic natural killer cell activity and serum interferon production in mice.
    Won SJ; Lin MT; Wu WL
    Jpn J Pharmacol; 1992 Jun; 59(2):171-6. PubMed ID: 1279250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo.
    Kasaian MT; Biron CA
    J Exp Med; 1990 Mar; 171(3):745-62. PubMed ID: 1689761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyporeactivity to interferon induction in newborn piglets.
    Derbyshire JB; Lesnick CE
    J Interferon Res; 1990 Feb; 10(1):47-53. PubMed ID: 1691769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of mu-opioid receptors are required for the conditioned enhancement of NK cell activity.
    Hsueh CM; Chen SF; Huang HJ; Ghanta VK; Hiramoto RN
    Brain Res; 1996 Oct; 737(1-2):263-8. PubMed ID: 8930374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of endogenous interferon-gamma on the enhancement of splenic NK cell activity by electroacupuncture stimulation in mice.
    Yu Y; Kasahara T; Sato T; Asano K; Yu G; Fang J; Guo S; Sahara M; Hisamitsu T
    J Neuroimmunol; 1998 Oct; 90(2):176-86. PubMed ID: 9817445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic differences in the age-associated decrease in inducibility of natural killer cells by interferon-alpha/beta.
    Plett A; Murasko DM
    Mech Ageing Dev; 2000 Jan; 112(3):197-215. PubMed ID: 10687925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethanol suppresses NK cell activation by polyinosinic-polycytidylic acid (poly I:C) in female B6C3F1 mice: role of endogenous corticosterone.
    Collier SD; Wu WJ; Pruett SB
    Alcohol Clin Exp Res; 2000 Mar; 24(3):291-9. PubMed ID: 10776665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of Leu-enkephalin and alpha-interferon in modulation of NK-activity of human peripheral blood lymphocytes.
    Gabrilovac J; Martin-Kleiner I; Ikić-Sutlić M; Osmak M
    Ann N Y Acad Sci; 1992 Apr; 650():140-5. PubMed ID: 1605472
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of endogenous and exogenous opioids on splenic natural killer cell activity.
    Kraut RP; Greenberg AH
    Nat Immun Cell Growth Regul; 1986; 5(1):28-40. PubMed ID: 3010087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
    Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR
    Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities.
    Reynolds CW; Brunda MJ; Holden HT; Herberman RB
    J Natl Cancer Inst; 1981 May; 66(5):837-42. PubMed ID: 6164813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TNF-alpha further augments natural killer cells when co-administered with an interferon inducer to irradiated, leukemic, bone-marrow-transplanted mice.
    Currier NL; Miller SC
    Cancer Chemother Pharmacol; 2001; 47(2):185-6. PubMed ID: 11269746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoferon (AM3) enhances the activities of early-type interferon inducers and natural killer cells.
    Moya P; Baixeras E; Barasoain I; Rojo JM; Ronda E; Alonso ML; Portolés A
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):243-56. PubMed ID: 2449486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement by interferon of chicken splenocyte natural killer cell activity against Marek's disease tumor cells.
    Ding AH; Lam KM
    Vet Immunol Immunopathol; 1986 Jan; 11(1):65-72. PubMed ID: 2420060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.